4th Quarter - Report

CEPHEID for CEPHEID

Period 4th Quarter 2021 Filed Jan 19, 2022 Signed by Angela M. Stewart

Official filing
Firm
CEPHEID
Client
CEPHEID
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

issues related to diagnostic testing and reimbursement related to COVID testing

LobbyistCovered position, as disclosed
MICHELE M SCHOONMAKER —
ANGELA STEWART Legislative Counsel, Senator John W. Warner (R-VA)

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID).

LobbyistCovered position, as disclosed
MICHELE M SCHOONMAKER —
ANGELA STEWART Legislative Counsel, Senator John W. Warner (R-VA)

Contacted: Health & Human Services, Dept of (HHS); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2209 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.